UK industry calls for debate on access to new medicines
This article was originally published in Scrip
Executive Summary
In the aftermath of NICE's proposal to reject four kidney cancer drugs for patients in England and Wales, the body that represents the UK pharmaceutical industry, theABPI, has called for professional organisations to publicly debate access to modern medicines.